Rik Rozemeijer
6PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 03, 2021
Clinical outcomes after permanent polymer or polymer-free stent implantation in patients with diabetes mellitus: The ReCre8 diabetes substudy.Nicole D van Hemert, Rik Rozemeijer, Michiel Voskuil
|Sep 21, 2020
Direct comparison of predictive performance of PRECISE-DAPT versus PARIS versus CREDO-Kyoto: a subanalysis of the ReCre8 trial.R Rozemeijer, W P van Bezouwen, N D van Hemert
|Mar 22, 2019
Incidence, angiographic and clinical predictors, and impact of stent thrombosis: a 6-year survey of 6,545 consecutive patients.R Rozemeijer, C Wing Wong, G Leenders
|Jan 04, 2019
One-year clinical outcomes of patients treated with polymer-free amphilimus-eluting stents or zotarolimus-eluting stents: A propensity-score adjusted analysis.Rik Rozemeijer, Ivar G van Muiden, Stefan Koudstaal
|Mar 16, 2018
Short versus long duration of dual antiplatelet therapy following drug-eluting stents: a meta-analysis of randomised trials.R Rozemeijer, M Voskuil, J P Greving
|May 26, 2017
Rationale and design of amphilimus sirolimus-eluting stents versus zotarolimus-eluting stents in all-comers requiring percutaneous coronary intervention (ReCre8): A multicenter randomized clinical trial.Rik Rozemeijer, Mèra Stein, Peter Frambach
Pageof 1
